Page last updated: 2024-10-27

fenoldopam and Carcinoma, Renal Cell

fenoldopam has been researched along with Carcinoma, Renal Cell in 2 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research Excerpts

ExcerptRelevanceReference
"Fenoldopam is a short-acting dopamine-1 receptor agonist that might provide renal protection during ischemic stress."2.78Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial. ( Bonilla, AM; Campbell, SC; Fergany, AF; Gill, IS; Kaouk, JH; Kaple, KM; Mahboobi, R; Mascha, EJ; Novak, SM; O'Hara, JF; Sessler, DI; Ziegman, SA, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Hara, JF1
Mahboobi, R1
Novak, SM1
Bonilla, AM1
Mascha, EJ1
Fergany, AF1
Campbell, SC1
Kaouk, JH1
Kaple, KM1
Gill, IS1
Ziegman, SA1
Sessler, DI1
Huang, WC1

Trials

1 trial available for fenoldopam and Carcinoma, Renal Cell

ArticleYear
Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.
    Urology, 2013, Volume: 81, Issue:2

    Topics: Acute Kidney Injury; Aged; Carcinoma, Renal Cell; Creatinine; Dopamine Agonists; Double-Blind Method

2013

Other Studies

1 other study available for fenoldopam and Carcinoma, Renal Cell

ArticleYear
Editorial comment.
    Urology, 2013, Volume: 81, Issue:2

    Topics: Acute Kidney Injury; Carcinoma, Renal Cell; Dopamine Agonists; Female; Fenoldopam; Glomerular Filtra

2013